Table 1.
Time (min) | Vehicle | CBD-PI (10 µg·kg−1) | CBD-PI (50 µg·kg−1) | CBD-PR (50 µg·kg−1) |
---|---|---|---|---|
MABP (mmHg) | ||||
−25 | 132 ± 3 | 119 ± 12 | 133 ± 4 | 127 ± 3 |
−10 | 132 ± 3 | 115 ± 8a | 134 ± 4a | 128 ± 2 |
−5 | 131 ± 3 | 113 ± 9 | 118 ± 5† | 127 ± 3 |
0 | 128 ± 3 | 110 ± 10 | 132 ± 2 | 129 ± 3 |
1 | 87 ± 5*** | 79 ± 7*** | 90 ± 5*** | 97 ± 5*** |
3 | 94 ± 6*** | 89 ± 7** | 97 ± 5*** | 108 ± 5** |
20 | 105 ± 4** | 80 ± 5*** | 112 ± 4** | 112 ± 4*b |
25 | 107 ± 4** | 86 ± 8** | 111 ± 3** | 110 ± 3* |
30 | 106 ± 4** | 80 ± 9*** | 108 ± 3** | 106 ± 2* |
31 | 103 ± 4 | 89 ± 11 | 109 ± 8 | 86 ± 8†† |
35 | 109 ± 4 | 95 ± 12 | 116 ± 6 | 97 ± 5 |
60 | 110 ± 5 | 92 ± 13 | 118 ± 3 | 101 ± 5 |
150 | 98 ± 3 | 99 ± 7 | 112 ± 3 | 108 ± 4 |
HR (BPM) | ||||
−25 | 438 ± 10 | 387 ± 35 | 404 ± 21 | 426 ± 13 |
−10 | 429 ± 8 | 412 ± 33a | 392 ± 20a | 429 ± 12 |
−5 | 431 ± 8 | 460 ± 35 | 396 ± 23 | 428 ± 15 |
0 | 429 ± 8 | 413 ± 48 | 401 ± 24 | 426 ± 15 |
1 | 429 ± 7 | 482 ± 26 | 406 ± 20 | 429 ± 13 |
3 | 425 ± 9 | 490 ± 48 | 404 ± 21 | 431 ± 13 |
20 | 401 ± 12 | 397 ± 52 | 383 ± 20 | 409 ± 15b |
25 | 394 ± 9 | 430 ± 38 | 386 ± 20 | 418 ± 12 |
30 | 394 ± 9 | 445 ± 35 | 387 ± 22 | 411 ± 15 |
31 | 384 ± 9 | 464 ± 26 | 393 ± 22 | 418 ± 13 |
35 | 386 ± 9 | 476 ± 26 | 382 ± 27 | 406 ± 16 |
60 | 380 ± 10 | 420 ± 17 | 380 ± 23 | 414 ± 14 |
150 | 380 ± 11 | 426 ± 27 | 389 ± 18 | 416 ± 13 |
CBD administered.
P < 0.05
P < 0.01 versus pre-injection value.
P < 0.05
P < 0.01
P < 0.001 versus pre-ischaemic value.
CBD, (-)-cannabidiol; CBD-PI, pre-ischaemia CBD-treated group; CBD-PR, pre-reperfusion CBD-treated group; HR, heart rate; MABP, mean arterial blood pressure.